Home › Novartis Launches Strenzen for Treatment of Respiratory, Enteric Diseases in Pigs
 

Keywords :   


Novartis Launches Strenzen for Treatment of Respiratory, Enteric Diseases in Pigs

2014-04-14 02:00:00| ThePigSite - Industry News

SWITZERLAND - Novartis Animal Health (NAH) announced today the launch of Strenzen® (amoxicillin, clavulanic acid), an oral water medication for pigs containing a combination of amoxicillin trihydrate (500 mg/g) and potassium clavulanate (125 mg/g) in ratio of 4:1.

Tags: treatment diseases respiratory launches

Category:Agriculture and Forestry

Latest from this category

All news
26.11Study reveals vast majority of feed outages due to bin slide management mistakes
26.11EPA releases draft farm emissions methodologies
26.11USDA Air Quality Task Force taps two from pork industry
26.112024 research dives into feeding practices, cleaning for improved PSY
26.11Farm Progress America, Nov. 26, 2024
26.11Farm Progress America, Nov. 26, 2024
25.11UPL, CH4 Global partner on methane-reducing cattle supplement
25.11Fed cattle prices edge higher
Agriculture and Forestry »
26.11
26.11 DVD
26.11W102
26.11 821
26.11
26.112 19
26.11 BROOKS B17 CHAMPION
26.11ENCODER
More »